Mesenchymal Stem Cells (MSC) Market Set to Surpass USD 9.72 Billion by 2032 | The Role of Biopharma Collaborations in Accelerating Growth
November 21, 2024 09:00 ET
|
SNS Insider pvt ltd
Austin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “The Mesenchymal Stem Cells (MSC) Market was valued at USD 3.2 Billion in 2023 and is projected to reach USD 9.72...
Spine Biologics Market to hit USD 3.4 billion by 2032, says Global Market Insights Inc.
August 28, 2023 17:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Spine Biologics Market size is expected to be worth USD 3.4 billion by 2032. The increasing prevalence of spine deformities is the major...
IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
September 09, 2022 09:22 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for...
Animal Stem Cell Therapy Market projected CAGR of 5.2% for the next ten years (2022-2032) – Persistence Market Research
June 27, 2022 09:00 ET
|
Persistence Market Research
New York, June 27, 2022 (GLOBE NEWSWIRE) -- The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the...
IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
February 16, 2022 09:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...
Mesenchymal Stem Cells Market Value Projected To Reach US$ 2,600.5 Million By 2027 Covering Pre and Post COVID-19 Market Analysis: Acumen Research and Consulting
May 19, 2021 11:34 ET
|
Acumen Research and Consulting
LOS ANGELES, May 19, 2021 (GLOBE NEWSWIRE) -- The Global Mesenchymal Stem Cells Market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and reach the market value of over US$ 2,600.5...
Global Autologous Cell Therapy Market Is Expected to Reach USD 42.68 Billion by 2027 : Fior Markets
September 09, 2020 16:00 ET
|
Fior Markets
Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global autologous cell therapy market is expected to grow from USD 9.29 billion in 2019 and to reach...
GenCure announces breakthrough first run of 80-liter bioreactor
August 13, 2019 09:10 ET
|
BioBridge Global
San Antonio, Texas, Aug. 13, 2019 (GLOBE NEWSWIRE) -- In a breakthrough for the regenerative medicine industry, GenCure announced today that its biomanufacturing services team has successfully...
Mesenchymal Stem Cells Market Advances and Applications – Market Growth and Future Analysis: ResearchMoz
March 22, 2016 08:00 ET
|
Researchmoz Global Pvt Ltd
Albany, NY, March 22, 2016 (GLOBE NEWSWIRE) -- The report explores the recent advancements in mesenchymal stem cell research applications and the competitive environment in the market. It further...
Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease
November 27, 2015 06:00 ET
|
Mesoblast Limited
MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has received...